1. American Society of Addiction Medicine. The ASAM National Practice Guideline for the treatment of opioid use disorder –2020 focused update. https://www.asam.org/quality-care/clinical-guidelines/national-practice-guideline.
2. Toward a typology of office-based buprenorphine treatment laws: Themes from a review of state laws;Andraka-Christou;Journal of Addiction Medicine,2022
3. Barriers rural physicians face prescribing buprenorphine for opioid use disorder;Andrilla;Annals of Family Medicine,2017
4. States can reduce barriers to prescribing buprenorphine for opioid use disorder;Connolly,2021
5. H.R.2617 - 117th Congress (2021-2022): Consolidated Appropriations Act, 2023. (2022). https://www.congress.gov/bill/117th-congress/house-bill/2617.